Drawing for THE NEW DIMENSION IN PHARMACEUTICAL COMPOUNDING

USPTO serial 76463251

THE NEW DIMENSION IN PHARMACEUTICAL COMPOUNDING

Reviewed by CopyMark Law Group

Reg. 2965542Status 710
Filing date
Status date
Registration date
Jul 12, 2005
Examiner
KING, CHRISTINA B
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with THE NEW DIMENSION IN PHARMACEUTICAL COMPOUNDING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas A. Rettew

Douglas A. Rettew Finnegan, Henderson, Farabow, Garrett & Dunner LLP901 New York Avenue, NWWashington, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
009ELECTRONIC PUBLICATIONS, NAMELY, BROCHURES, MAGAZINES AND NEWSLETTERS IN THE FIELD OF PHARMACEUTICALS AND/OR PHARMACEUTICAL COMPOUNDING, RECORDED ON COMPUTER MEDIA; DOWNLOADABLE ELECTRONIC PUBLICATIONS, NAMELY, BROCHURES, MAGAZINES AND NEWSLETTERS IN THE FIELD OF PHARMACEUTICALS AND/OR PHARMACEUTICAL COMPOUNDINGSECTION 8 - CANCELLED—
016PRINTED PUBLICATIONS, NAMELY, BROCHURES, MAGAZINES AND NEWSLETTERS IN THE FIELD OF PHARMACEUTICALS AND/OR PHARMACEUTICAL COMPOUNDINGSECTION 8 - CANCELLED—
041CONDUCTING WORKSHOPS AND SEMINARS IN THE FIELD OF PHARMACEUTICAL COMPOUNDING; CONDUCTING ONLINE WORKSHOPS AND SEMINARS IN THE FIELD OF PHARMACEUTICAL COMPOUNDINGSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2026CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jul 12, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 28, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 28, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 28, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 26, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Mar 25, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 25, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 25, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 21, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 21, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 16, 2015NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jul 16, 2015RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jul 16, 201589AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jul 16, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 23, 2015E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 5, 2012NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 5, 2012C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 5, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 12, 2012E815TEAS SECTION 8 & 15 RECEIVED—
Sep 11, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 12, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 19, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 30, 2005NPUBNOTICE OF PUBLICATION—
Jan 19, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 14, 2005ALIEASSIGNED TO LIE—
Jan 11, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 17, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 17, 2004MAILPAPER RECEIVED—
Jul 1, 2004CNSLLETTER OF SUSPENSION MAILED—
Jun 27, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 16, 2004IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 8, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 16, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2004NPUBNOTICE OF PUBLICATION—
Jan 6, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 3, 2003CFITCASE FILE IN TICRS—
Sep 29, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 29, 2003UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Sep 29, 2003MAILPAPER RECEIVED—
Mar 27, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2003DOCKASSIGNED TO EXAMINER—
Dec 11, 2002MAILPAPER RECEIVED—

Frequently asked questions

Related guidance